| 17th Oct 2019 7:00 am |
RNS |
Partnership with CDPHP on KidneyIntelX |
| 14th Oct 2019 7:00 am |
RNS |
Board appointment |
| 1st Oct 2019 7:00 am |
RNS |
US CPT® reimbursement code effective |
| 30th Sep 2019 4:37 pm |
RNS |
Result of AGM |
| 30th Sep 2019 8:00 am |
RNS |
Update on non-executive director appointment |
| 30th Sep 2019 7:00 am |
RNS |
Preliminary Medicare Pricing Determination |
| 6th Sep 2019 4:00 pm |
RNS |
Posting of Annual Report & Accounts &Notice of AGM |
| 3rd Sep 2019 7:00 am |
RNS |
Final Results |
| 20th Aug 2019 7:00 am |
RNS |
Notice of Results |
| 6th Aug 2019 7:00 am |
RNS |
Expansion of Chronic Kidney Disease Advisory Board |
| 31st Jul 2019 4:30 pm |
RNS |
Total Voting Rights |
| 29th Jul 2019 7:00 am |
RNS |
Thomas McLain Appointed as President and CCO |
| 23rd Jul 2019 6:23 pm |
RNS |
Result of Placing & Total Voting Rights |
| 23rd Jul 2019 7:01 am |
RNS |
Proposed Placing to raise £12.0m (c.US$15.0m) |
| 12th Jul 2019 7:00 am |
RNS |
US Exec Order on Advancing American Kidney Health |
| 9th Jul 2019 7:00 am |
RNS |
Positive Interim Results for Validation Study |
| 8th Jul 2019 7:00 am |
RNS |
FractalDx Positive Results Published in JASN |
| 1st Jul 2019 7:00 am |
RNS |
US CPT® Code Granted for KidneyIntelX(TM) |
| 7th Jun 2019 7:00 am |
RNS |
Positive results from FractalDx study published |
| 4th Jun 2019 7:00 am |
RNS |
KidneyIntelX commercial scale production milestone |
| 28th May 2019 7:00 am |
RNS |
CLIA Certificate Number issued for Renalytix Lab |
| 21st May 2019 7:00 am |
RNS |
Expansion of FractalDx core investigator group |
| 7th May 2019 7:00 am |
RNS |
University Medical Center Groningen collaboration |
| 2nd May 2019 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 2nd May 2019 2:00 pm |
RNS |
Price Monitoring Extension |
| 2nd May 2019 7:00 am |
RNS |
FDA grants Breakthrough Device designation |
| 26th Apr 2019 6:20 pm |
RNS |
Acquisition of further interest in Renalytix AI |
| 26th Apr 2019 5:42 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Apr 2019 12:55 pm |
RNS |
Holding(s) in Company |
| 1st Apr 2019 7:00 am |
RNS |
Publication of confirmation study results |
| 25th Mar 2019 7:00 am |
RNS |
Half-year Report |
| 22nd Mar 2019 7:00 am |
RNS |
RenalytixAI Forms Core Investigator Group |
| 12th Mar 2019 7:00 am |
RNS |
Investor briefing |
| 14th Feb 2019 7:00 am |
RNS |
Appointment of Nomad and Joint Broker |
| 13th Feb 2019 7:00 am |
RNS |
Joint venture partnership agreement with AKESOgen |
| 6th Feb 2019 7:00 am |
RNS |
RenalytixAI Expands Leadership Team |
| 23rd Jan 2019 7:00 am |
RNS |
Initiates Clinical Validation Study |
| 21st Jan 2019 7:00 am |
RNS |
Clarification re. lock-up restrictions |
| 2nd Jan 2019 7:00 am |
RNS |
Exercise of Option for Exclusive License |
| 20th Dec 2018 5:20 pm |
RNS |
Director/PDMR Shareholding |
